In May 2026, investigators from the MHRA's Criminal Enforcement Unit walked into a country estate near Northampton and found around 12,000 doses of unlicensed weight loss medicine waiting to be dispatched. It was the largest seizure of its kind the agency has ever made. Two men, both aged 29, were arrested on suspicion of offences under the Human Medicines Regulations 2012.
It was the third such site dismantled in seven months.
This matters because of who the buyers are. Not people cutting corners for fun, but people who have been told by a polished website or a messaging app account that there is a newer, stronger weight loss medicine available now, quietly, for less than a clinic would charge. There is a real drug behind that pitch. What is being sold is almost certainly not it.
Three factories in seven months
The sequence is worth reading in order, because it shows an industry scaling up rather than being scared off.
October 2025, Northampton. The MHRA, working with Northamptonshire Police, dismantled what is believed to have been the UK's first illicit weight loss medicine manufacturing facility. Investigators found tens of thousands of empty injection devices, raw ingredients, packaging, manufacturing equipment, around £20,000 in cash, and more than 2,000 unlicensed doses of retatrutide and tirzepatide awaiting dispatch. The finished product had a street value above £250,000. At the time, the MHRA believed it to be the largest single seizure of trafficked weight loss medicines recorded anywhere in the world.
February 2026, Lincolnshire. A farm near Sleaford and a residential address in Grantham were raided by the MHRA with Lincolnshire Police, Immigration Enforcement and Lincolnshire Trading Standards. Almost 2,000 doses were seized, along with manufacturing equipment, suspected active ingredients and commercial vehicles.
May 2026, Northampton again. Around 12,000 doses, the arrests described above, and a blunt line from Andy Morling, who heads the Criminal Enforcement Unit: "Medicines regulation isn't discretionary. It exists to protect people."
Zoom out and the scale is larger still. The MHRA reported that during 2025 it seized almost 20 million doses of illegally traded medicines with a street value of around £45 million, and worked with internet service providers to disrupt more than 1,500 websites and social media accounts. A separate two week border operation in March 2026 intercepted over two million doses of illicit medicines worth around £4.6 million.
The drug this is being sold as
The molecule named in all three UK raids is retatrutide, an investigational medicine developed by Eli Lilly. It is genuinely interesting, and that is precisely why it has a black market.
It is a once weekly injection that acts on three receptors rather than one or two, adding a glucagon arm that raises energy expenditure on top of the appetite suppression the licensed medicines rely on. In a published Phase 2 trial of 338 adults with obesity, participants on the highest dose lost 24.2% of their body weight over 48 weeks, against 2.1% on placebo.
Now the part the sellers leave out. As things stand it holds no marketing authorisation in any country in the world. The MHRA states plainly that it "has not been approved for UK use", and that outside authorised clinical trials, any products sold in the UK claiming to contain it are "likely to be illegal and are potentially dangerous to people's health". The US regulator is equally direct: retatrutide and compounds like it "have not been found safe and effective for any condition".
The manufacturer's own standing statement is the clearest sentence anyone has written on this. Retatrutide is legally available only to participants in Lilly's clinical trials, anyone purporting to sell it for human use is breaking the law, and nobody should consider taking anything claiming to be it outside a Lilly sponsored trial.
That same Phase 2 trial also recorded the sort of thing an unregulated vial cannot warn you about. Cardiac arrhythmias occurred in 6% of participants overall, reaching 14% in one dose arm against 3% on placebo. Between 6% and 16% of participants stopped treatment because of side effects. There is no approved dose, no summary of product characteristics and no authorised list of contraindications anywhere in the world, because no regulator has ever assessed one.
What is actually in the vial
"Unlicensed" sounds like a technicality. It is not. Licensing is the mechanism by which somebody independent checks both the medicine and the factory.
The MHRA's description of what that absence means is worth quoting in full. An unauthorised medicine "will not have been assessed by the MHRA for its safety, effectiveness or the quality and hygiene of its manufacturing and distribution processes", and anyone buying one "cannot be sure what it contains or whether it will cause them harm". Seized products, the agency adds, "can contain too much or too little of the declared active ingredient and may also contain other harmful ingredients". Andy Morling has been blunter still: some "may even be contaminated with toxic substances", and the products recovered in Northampton were described as "untested, unauthorised, and potentially deadly".
The practical failure modes stack up quickly. Peptides degrade if they are not kept cold, and the FDA has received complaints of products arriving warm or with inadequate ice packs. A Guardian investigation into a seller linked to the October raid, which carried on trading afterwards through a messaging app and a website, documented risks of wrong ingredients, wrong dosages and failing sterilisation standards. One buyer reported severe gastrointestinal problems, erratic energy and dehydration.
A Channel 4 News investigation reported by The Independent found the product being sold openly on Facebook and TikTok. An undercover reporter bought one, and the seller falsely claimed the injections came from a pharmacy and were available on the NHS, then gave conflicting instructions for using it. An NHS GP shown one of the packages expressed serious concerns about patient safety. In the same reporting, a woman described losing vision in one eye after using a copied weight loss drug bought on TikTok.
A medicine no regulator on earth has approved is not one that has been kept from you. It is one nobody has finished checking.
Why no clinic can offer it either, including this one
People sometimes assume the barrier is squeamishness, and that a private clinic willing to carry the risk could simply supply it. It cannot, and the reason is statutory.
Under the Human Medicines Regulations 2012, an advertisement may not be published for a medicinal product unless a UK marketing authorisation is in force, and a person may not publish an advertisement likely to lead to the use of a prescription only medicine. No authorisation exists here, so no wording, disclaimer or price makes promoting it lawful. Waiting lists and register your interest forms are caught by the same rule. In August 2026 the manufacturer filed six lawsuits in the United States against sellers that included compounding pharmacies and medical spas, alleging that research use only labelling was being used to disguise intended human use.
So, the honest position, stated once. Retatrutide is not available here, it is not lawfully available anywhere in the UK outside registered clinical trials, and we do not source it, supply it, prescribe it or keep a list for it.
The route that does exist
None of this means there is nothing to be done about weight that will not shift. It means the shortcut is a bad one.
If a medicine is the right tool, licensed options exist and are prescribed after an assessment that considers your history, your other medicines and your risk, by somebody accountable for that decision. Our weight loss programmes start from that assessment rather than from a product, and our guide to buying weight loss medication online safely covers how to check a pharmacy is registered before you hand over a card. If you are unsure where you sit clinically, the BMI calculator is a reasonable starting point, though it is a screening tool rather than a diagnosis.
If your goal is shape rather than scale weight, that is a genuinely different question, and treatments such as fat freezing address a small pocket of fat rather than body weight overall. Neither is a substitute for the other, and any clinic saying otherwise is selling.
And if you have already used something bought this way, please speak to a GP or call 111, especially with vomiting, severe abdominal pain, palpitations or any change in vision. Take the packaging with you, and report the reaction through the MHRA Yellow Card scheme.
The most useful thing to hold onto is the simplest. There is a reason the price is lower, and it is not efficiency. It is that nobody in the chain is accountable for what is in the bottle.
If you would like an honest assessment of what is realistic for you, and what is not, book a consultation at one of our clinics.
Judging where a weight loss medicine has come from
Signs a supply route is lawful
- The medicine holds a UK marketing authorisation, so the MHRA has assessed its safety, its effectiveness and the hygiene of the factory that made it
- It is dispensed by a pharmacy registered with the General Pharmaceutical Council, against a prescription written after a real clinical assessment
- It arrives with a patient information leaflet, a named batch and an expiry date, and there is a route for reporting side effects
Red flags that mean walk away
- It is sold through social media, a messaging app or a site with no registered pharmacy details, and no prescriber ever assesses you
- The product is labelled research use only or not for human consumption, which is a known evasion tactic rather than a legal safeguard
- It arrives warm, without refrigeration, or with no instructions at all, and there is no way to verify what is actually in the vial
Frequently Asked Questions
Is it illegal to buy weight loss medicines online in the UK?
Buying from a pharmacy registered with the General Pharmaceutical Council, against a prescription issued after a proper assessment, is lawful and routine. Buying a medicine that holds no UK marketing authorisation is a different matter. The MHRA states that products sold in the UK claiming to contain retatrutide, outside authorised clinical trials, are likely to be illegal and potentially dangerous to health. The criminal exposure sits mainly with the sellers, but the health risk sits entirely with the buyer.
What is actually wrong with an unlicensed medicine?
Licensing is not paperwork. In the MHRA's own words, an unauthorised medicine has not been assessed for its safety, its effectiveness, or the quality and hygiene of the processes used to make and distribute it. Seized products have been found to contain too much or too little of the declared active ingredient, and to contain other harmful ingredients. Nobody buying one can be sure what is in it.
I have already used something I bought online. What should I do?
Stop using it and speak to a GP or call 111, particularly if you have vomiting, severe abdominal pain, palpitations, or any change in your vision. Take the packaging with you. You can also report a suspected reaction through the MHRA Yellow Card scheme, and report the seller to the MHRA, which is how several of these investigations began.
Will this drug be licensed in the UK eventually?
Possibly, but nobody can give you a date. Its manufacturer has said it intends to submit a United States application in the first quarter of 2027. No UK marketing authorisation application appears in MHRA public records at all. Any specific UK availability date quoted online is speculation, and it is usually being quoted by somebody who wants to sell you something in the meantime.
Can a private clinic prescribe it if I pay?
No. There is no lawful supply chain for it in the United Kingdom outside a registered clinical trial or the manufacturer's own narrow expanded access programme. A clinic offering it, taking deposits for it, or keeping an interest list for it is not being enterprising. It is exposed to the same criminal framework the MHRA has already used to make arrests.
